Hexagon Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100
| Closed | -$12.8K | – | 830 |
|
|
2025
Q1 | $12.8K | Sell |
100
-307
| -75% | -$39.3K | ﹤0.01% | 894 |
|
|
2024
Q4 | $53.8K | Buy |
407
+307
| +307% | +$40.6K | 0.01% | 455 |
|
|
2024
Q3 | $14.6K | Hold |
100
| – | – | ﹤0.01% | 811 |
|
|
2024
Q2 | $13.7K | Hold |
100
| – | – | ﹤0.01% | 788 |
|
|
2024
Q1 | $13.7K | Hold |
100
| – | – | ﹤0.01% | 769 |
|
|
2023
Q4 | $13.6K | Hold |
100
| – | – | ﹤0.01% | 755 |
|
|
2023
Q3 | $12.2K | Hold |
100
| – | – | ﹤0.01% | 689 |
|
|
2023
Q2 | $12.7K | Hold |
100
| – | – | ﹤0.01% | 683 |
|
|
2023
Q1 | $12.9K | Hold |
100
| – | – | ﹤0.01% | 670 |
|
|
2022
Q4 | $13.1K | Hold |
100
| – | – | ﹤0.01% | 657 |
|
|
2022
Q3 | $12K | Hold |
100
| – | – | ﹤0.01% | 719 |
|
|
2022
Q2 | $12K | Buy |
+100
| New | +$12K | ﹤0.01% | 622 |
|